BSEZenotech Laboratories LtdMinimalNeutral
Announced Wed, 27 May · 17:30 IST

Submission of Annual Secretarial Compliance Report for the financial year 2025-26

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.9%1-day move
₹44.80
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.9+0.2-0.9+0.4-1.2-0.6-0.5-0.4
Up moveDown movePending
AI summary

Zenotech Laboratories Ltd has filed its Annual Secretarial Compliance Report for FY 2025-26, prepared by Practicing Company Secretary Mahadev Tirunagari. The company has largely complied with applicable SEBI regulations, secretarial standards, related party transaction requirements, and insider trading norms during the review period. One observation was noted regarding Regulation 46: the company has not uploaded subsidiary financial statements on its website due to missing records from overseas subsidiaries, making consolidated financial statements preparation impossible. The company has written off investments in these subsidiaries. This is a recurring observation from FY 2020-21 through FY 2024-25. No SEBI or stock exchange actions were taken against the company during the period.

Likely market impact

The compliance report shows mostly satisfactory statutory adherence, but the persistent issue with overseas subsidiary records since 2020 indicates potential governance gaps in subsidiary oversight. For shareholders, this suggests the company is in good regulatory standing with SEBI, though the inability to consolidate subsidiary financials and complete RBI filings may raise questions about historical data management.